亚临床甲状腺功能亢进症与心血管疾病
本叙述性综述评估普通人群中亚临床甲状腺功能亢进症(SCHyper)与心血管疾病(CVD)的关联。证据表明SCHyper与心房颤动、心力衰竭、主要不良心脏事件、CVD死亡率和全因死亡率风险升高相关,与卒中风险关联较小,与冠心病风险结果不一致。TSH抑制程度(<0.1 mIU/L)者CVD风险高于TSH低值(0.1-0.4 mIU/L)者,治疗决策应基于具体风险因素个体化。
要点
- SCHyper与心房颤动、心力衰竭、MACE、CVD死亡率和全因死亡率风险升高相关。
- SCHyper与卒中风险关联较小,与冠心病风险结果不一致。
- TSH<0.1 mIU/L者CVD风险高于TSH 0.1-0.4 mIU/L者,治疗应个体化。
核心结论
- SCHyper与心房颤动、心力衰竭、MACE、CVD死亡率和全因死亡率风险升高相关。
- 考虑血清TSH抑制程度和年龄作为CVD风险因素的重要性,治疗决策应基于具体风险因素个体化。
研究设计与样本
- 叙述性综述,评估普通人群中SCHyper与CVD关联的已发表数据。
主要发现
- SCHyper与心房颤动、心力衰竭、MACE、CVD死亡率和全因死亡率风险升高相关。
- SCHyper与卒中风险关联较小,与冠心病风险结果不一致。
- TSH<0.1 mIU/L的SCHyper个体CVD风险高于TSH 0.1-0.4 mIU/L者。
- 尽管老年人CVD风险固有较高,尚无研究证明SCHyper中CVD相对风险随年龄增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: In this narrative review, we assess published data on subclinical hyperthyroidism (SCHyper) and its association with cardiovascular disease (CVD) in the general population. Summary: We present data on the risk of SCHyper in relation to CVD outcomes, including atrial fibrillation (AF), heart failure, stroke, coronary heart disease (CHD), major adverse cardiac events (MACE), CVD mortality, and all-cause mortality. Evidence indicates that SCHyper is associated with an elevated risk of AF, heart failure, MACE, CVD mortality, and all-cause mortality. SCHyper appears to have little association with stroke risk and has shown conflicting results regarding CHD risk. Regarding the degree of serum TSH suppression, evidence shows a higher risk of CVD in SCHyper individuals with suppressed TSH (<0.1 mIU/L) compared with those with low TSH (0.1-0.4 mIU/L). Despite evidence that older individuals are inherently at a higher risk for CVD, no studies have yet demonstrated an age-related increase in the relative risk of CVD in SCHyper. Conclusion: The studies indicate that SCHyper is associated with an increased risk of AF, heart failure, MACE, CVD mortality, and all-cause mortality. Considering the importance of the degree of serum TSH suppression and age as risk factors for CVD, treatment decisions should be individualized based on their specific risk factors.
引用
- Kim HJ, McLeod DSA. Subclinical Hyperthyroidism and Cardiovascular Disease. Thyroid. 2024. PMID: 39283826. doi:10.1089/thy.2024.0291
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。